Home NDC 31722-419 LISINOPRIL
Product NDC 31722-419
11-digit product format 317220419
Labeler code 31722
Product ID 31722-419_059f5795-5de9-4a69-bced-580cf6272799
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name LISINOPRIL
Dosage form TABLET
Route ORAL
Labeler Camber Pharmaceuticals Inc.
Application ANDA203508
Marketing category ANDA
Marketing start 2013-11-15
Marketing end 0000-00-00
Substance LISINOPRIL
Active strength 10 mg/1
Pharmacologic classes Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 2 · 110 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 31722-419-10 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 31722-419-30 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 31722-419-05 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 31722-419-01 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 31722-419-10 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 31722-419-30 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 31722-419-05 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 31722-419-01 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 31722-419-10 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 31722-419-30 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 31722-419-05 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 31722-419-01 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 31722-419-10 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 31722-419-30 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 31722-419-05 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 31722-419-01 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 31722-419-10 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 31722-419-30 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 31722-419-05 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 31722-419-01 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 31722-419-10 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 31722-419-30 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 31722-419-05 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 31722-419-01 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 31722-419-10 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 31722-419-01 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 31722-419-05 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 31722-419-30 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 31722-419-10 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 31722-419-01 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 31722-419-05 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 31722-419-30 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 31722-419-10 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 31722-419-01 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 31722-419-05 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 31722-419-30 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 31722-419-10 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 31722-419-01 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 31722-419-05 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 31722-419-30 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 31722-419-10 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 31722-419-01 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 31722-419-05 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 31722-419-30 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 31722-419-10 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 31722-419-01 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 31722-419-05 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 31722-419-30 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A203508-001 LISINOPRIL LISINOPRIL 2.5MG TABLET / ORAL AB 2013-10-29 A203508-002 LISINOPRIL LISINOPRIL 5MG TABLET / ORAL AB 2013-10-29 A203508-003 LISINOPRIL LISINOPRIL 10MG TABLET / ORAL AB 2013-10-29 A203508-004 LISINOPRIL LISINOPRIL 20MG TABLET / ORAL AB 2013-10-29 A203508-005 LISINOPRIL LISINOPRIL 30MG TABLET / ORAL AB 2013-10-29 A203508-006 LISINOPRIL LISINOPRIL 40MG TABLET / ORAL AB 2013-10-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 6 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 7 · 252 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A203508-001 LISINOPRIL 2.5MG TABLET / ORAL AB 2013-10-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A203508-002 LISINOPRIL 5MG TABLET / ORAL AB 2013-10-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A203508-003 LISINOPRIL 10MG TABLET / ORAL AB 2013-10-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A203508-004 LISINOPRIL 20MG TABLET / ORAL AB 2013-10-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A203508-005 LISINOPRIL 30MG TABLET / ORAL AB 2013-10-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A203508-006 LISINOPRIL 40MG TABLET / ORAL AB 2013-10-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A203508-001 LISINOPRIL 2.5MG TABLET / ORAL AB 2013-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A203508-002 LISINOPRIL 5MG TABLET / ORAL AB 2013-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A203508-003 LISINOPRIL 10MG TABLET / ORAL AB 2013-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A203508-004 LISINOPRIL 20MG TABLET / ORAL AB 2013-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A203508-005 LISINOPRIL 30MG TABLET / ORAL AB 2013-10-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A203508-006 LISINOPRIL 40MG TABLET / ORAL AB 2013-10-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203508-001 LISINOPRIL 2.5MG TABLET / ORAL AB 2013-10-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203508-002 LISINOPRIL 5MG TABLET / ORAL AB 2013-10-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203508-003 LISINOPRIL 10MG TABLET / ORAL AB 2013-10-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203508-004 LISINOPRIL 20MG TABLET / ORAL AB 2013-10-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203508-005 LISINOPRIL 30MG TABLET / ORAL AB 2013-10-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203508-006 LISINOPRIL 40MG TABLET / ORAL AB 2013-10-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A203508-001 LISINOPRIL 2.5MG TABLET / ORAL AB 2013-10-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A203508-002 LISINOPRIL 5MG TABLET / ORAL AB 2013-10-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A203508-003 LISINOPRIL 10MG TABLET / ORAL AB 2013-10-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A203508-004 LISINOPRIL 20MG TABLET / ORAL AB 2013-10-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A203508-005 LISINOPRIL 30MG TABLET / ORAL AB 2013-10-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A203508-006 LISINOPRIL 40MG TABLET / ORAL AB 2013-10-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203508-001 LISINOPRIL 2.5MG TABLET / ORAL AB 2013-10-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203508-002 LISINOPRIL 5MG TABLET / ORAL AB 2013-10-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203508-003 LISINOPRIL 10MG TABLET / ORAL AB 2013-10-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203508-004 LISINOPRIL 20MG TABLET / ORAL AB 2013-10-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203508-005 LISINOPRIL 30MG TABLET / ORAL AB 2013-10-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203508-006 LISINOPRIL 40MG TABLET / ORAL AB 2013-10-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203508-001 LISINOPRIL 2.5MG TABLET / ORAL AB 2013-10-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203508-002 LISINOPRIL 5MG TABLET / ORAL AB 2013-10-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203508-003 LISINOPRIL 10MG TABLET / ORAL AB 2013-10-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203508-004 LISINOPRIL 20MG TABLET / ORAL AB 2013-10-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203508-005 LISINOPRIL 30MG TABLET / ORAL AB 2013-10-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203508-006 LISINOPRIL 40MG TABLET / ORAL AB 2013-10-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203508-001 LISINOPRIL 2.5MG TABLET / ORAL AB 2013-10-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203508-002 LISINOPRIL 5MG TABLET / ORAL AB 2013-10-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203508-003 LISINOPRIL 10MG TABLET / ORAL AB 2013-10-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203508-004 LISINOPRIL 20MG TABLET / ORAL AB 2013-10-29 03ed91905a0d…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 7 · 252 observed states.
FDA-Initiated Inactive NDC Indexing# NDC, Effective, Related label table NDC Effective Related label 31722-419-01 2025-02-20 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Lisinopril Tablets safely and effectively. See full prescribing information for Lisinopril Tablets Lisinopril Tablets, USP for oral use Initial U.S. Approval: 1988 31722-419-05 2025-02-20 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Lisinopril Tablets safely and effectively. See full prescribing information for Lisinopril Tablets Lisinopril Tablets, USP for oral use Initial U.S. Approval: 1988 31722-419-10 2025-02-20 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Lisinopril Tablets safely and effectively. See full prescribing information for Lisinopril Tablets Lisinopril Tablets, USP for oral use Initial U.S. Approval: 1988 31722-419-30 2025-02-20 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Lisinopril Tablets safely and effectively. See full prescribing information for Lisinopril Tablets Lisinopril Tablets, USP for oral use Initial U.S. Approval: 1988 31722-419-01 2020-01-31 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Lisinopril Tablets safely and effectively. See full prescribing information for Lisinopril Tablets Lisinopril Tablets, USP for oral use Initial U.S. Approval: 1988 31722-419-05 2020-01-31 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Lisinopril Tablets safely and effectively. See full prescribing information for Lisinopril Tablets Lisinopril Tablets, USP for oral use Initial U.S. Approval: 1988 31722-419-10 2020-01-31 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Lisinopril Tablets safely and effectively. See full prescribing information for Lisinopril Tablets Lisinopril Tablets, USP for oral use Initial U.S. Approval: 1988 31722-419-30 2020-01-31 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Lisinopril Tablets safely and effectively. See full prescribing information for Lisinopril Tablets Lisinopril Tablets, USP for oral use Initial U.S. Approval: 1988
DailyMed Socrata Ingredients# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.